H. Lundbeck A/S
HLUN B
ISIN DK0061804770 / Valor 119252587
H. Lundbeck A/S
UMushroom community rating:
About company
H. Lundbeck A/S is a global pharmaceutical company headquartered in Denmark, with a presence in over 50 countries. The company specializes in developing and marketing innovative treatments for brain diseases, leveraging its production facilities in Denmark, France, and Italy, and research centers in Denmark and the United States. Since its public listing on Nasdaq Copenhagen in 1999, Lundbeck has been primarily owned by the Lundbeck Foundation, which holds approximately 70% of its shares and supports medical research and educational initiatives. With a history spanning over 70 years, Lundbeck has been instrumental in providing therapies that address neurological and psychiatric disorders, impacting millions of patients worldwide.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
4730 M
Market cap (USD)
374,255
Daily traded volume (Shares)
42.24 / 41.3
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
